Acta Haematologica

Papers
(The TQCC of Acta Haematologica is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Treating Leukemia in the Time of COVID-1944
Systematic Review of Microthrombi in COVID-19 Autopsies33
Red Blood Cell Distribution Is a Significant Predictor of Severe Illness in Coronavirus Disease 201926
Accelerated Phase of Myeloproliferative Neoplasms26
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic26
Hematological Manifestations among Patients with Rheumatic Diseases21
COVID-19 Coagulopathy: From Pathogenesis to Treatment18
The Association between Metabolic Syndrome and Multiple Myeloma18
Coronavirus Disease 2019 (COVID-19): A Haematologist’s Perspective17
G-CSF and GM-CSF Are Different. Which One Is Better for COVID-19?15
A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations15
Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel15
Current Treatment of Refractory/Relapsed Chronic Lymphocytic Leukemia: A Focus on Novel Drugs13
Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia an13
JAK/STAT Pathway Inhibition May Be a Promising Therapy for COVID-19-Related Hyperinflammation in Hematologic Patients12
The Efficacy of Etoposide-Based Therapy in Adult Secondary Hemophagocytic Lymphohistiocytosis11
Perspective: SARS-CoV-2, COVID-19 and Haematologists10
Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant10
Adherence to Immunization: Rebuttal of Vaccine Hesitancy10
Management of Persistent SARS-CoV-2 Infection in Patients with Follicular Lymphoma9
Consolidation Treatment for Primary Central Nervous System Lymphoma: Which Modality for Whom?9
ALK-Positive Histiocytosis with Peripheral Blood Histiocytes: A Case Report9
Current Understandings of Myeloid Differentiation Inducers in Leukemia Therapy9
Low Prevalence of Antibodies to SARS-CoV-2 and Undetectable Viral Load in Seropositive Blood Donors from South-Eastern Italy8
Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk8
<b><i>BCR/ABL1</i></b>-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy8
COVID-19 in Patients with Hematologic Malignancies: Clinical Manifestations, Persistence, and Immune Response8
Is G-CSF Dangerous in COVID-19: Why Not Use GM-CSF?8
Clonal Megakaryocyte Dysplasia with Normal Blood Values Is a Distinct Myeloproliferative Neoplasm8
Multiple Myeloma Presenting in Patients Younger than 50 Years of Age: A Single Institution Experience7
Current and Emerging Treatments for Waldenström Macroglobulinemia7
Ruxolitinib for Severe COVID-19-Related Hyperinflammation in Nonresponders to Steroids7
Deoxycytidine Kinase (DCK) Mutations in Human Acute Myeloid Leukemia Resistant to Cytarabine7
Pure Red Cell Aplasia following ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation: Resolution with Daratumumab Treatment7
Vaccination for SARS-CoV-2 in Hematological Patients7
Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients6
Kinase Inhibitors and Interferons as Other Myeloid Differentiation Inducers in Leukemia Therapy6
Prognostic Impact of Peripheral Blood T-Cell Subsets at the Time of Diagnosis on Survival in Patients with Diffuse Large B-Cell Lymphoma6
Ibrutinib in Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Lower Risk of Hepatitis B Virus Reactivation6
Relationship of Thrombospondin 1 to von Willebrand Factor and ADAMTS-13 in Sickle Cell Disease Patients of Arab Ethnicity6
Viscoelastic Coagulation Monitor (VCM<sup>Vet</sup>) Reference Intervals and Sex Differences in Mature Adult Mice6
Dramatic Recovery after Etoposide Phosphate Infusion for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome following Treatment with Tisagenlecleucel in a Young Patient with Relapsed Ac6
An Early Unexpected Immune Thrombotic Thrombocytopenic Purpura Relapse Associated with SARS-CoV-2 Infection: A Case Report and Literature Review6
A Case of Hemophagocytic Lymphohistiocytosis following Second Dose of COVID-19 Vaccination6
COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments6
Two Novel Variants in the Protein S Gene PROS1 Are Associated with Protein S Deficiency and Thrombophilia5
Management of COVID-19 Coagulopathy in a Patient with Severe Haemophilia A5
Using Circ-ANAPC7 as a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia5
Absolute Immature Platelet Counts Suggest Platelet Production Suppression during Complicated Relapsing Thrombotic Thrombocytopenic Purpura5
Progressive Multifocal Leukoencephalopathy in Relapsed Ph+ Acute Lymphoblastic Leukemia after Cord Blood Transplantation and Blinatumomab Treatment: A Case Report and Literature Review4
Increased Incidence of Thrombosis in a Cohort of Cancer Patients with COVID-194
Myeloid Sarcoma: Diagnostic and Treatment Tools from a Monocentric Retrospective Experience4
Threshold of Serum Ferritin to Discriminate against Those at Greater Risk of Platelet Increase during Treatment with Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitor4
How Do We Manage Hematopoietic Cell Transplant during the SARS-CoV-2 Pandemic?4
Concomitant Primary Hyperparathyroidism in Patients with Multiple Myeloma: A Possible Link?4
Clinical Significance of Plasma Epstein-Barr Virus DNA in Peripheral T-Cell Lymphomas4
Very Early Increased Platelet Count within a Week after Initiation of High-Dose Dexamethasone Treatment Is Associated with Long-Term Response in Newly Diagnosed Immune Thrombocytopenia Patients4
COVID-19 Infection in Sickle Cell Patients in a Developing Country: A Case Series4
Concomitant Immunosuppressive Therapy and Eculizumab Use in Patients with Paroxysmal Nocturnal Hemoglobinuria: An International PNH Registry Analysis4
Effectiveness and Safety of Pixantrone for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Every-Day Clinical Practice: The Italian Cohort of the PIXA Registry4
Clonal Megakaryocyte Dysplasia with Isolated Thrombocytosis Is a Distinct Myeloproliferative Neoplasm Phenotype4
Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation4
Ruxolitinib in COVID-19 Hyperinflammation and Haematologic Malignancies4
Plasma Exchange as an Initial Treatment for Severe Bleeding Induced by Acquired Factor V Deficiency: A Case Report and Mini Literature Review4
Efficacy of Individualized Preventive Treatment of Patients with Severe Hemophilia A Guided by Multiple Clinical Parameters and Pharmacokinetics4
Eltrombopag for the Treatment of Severe Inherited Thrombocytopenia4
<b><i>DIAPH1</i></b> Mutation as a Novel Cause of Autosomal Dominant Macrothrombocytopenia and Hearing Loss4
Pretreatment Immature Platelet Fraction as a Surrogate of Reticulated Platelets Predicts the Response to Corticosteroids in Adults with Immune Thrombocytopenia4
Successful Treatment of the TEMPI Syndrome with Pomalidomide Plus Dexamethasone Followed by Autologous Stem Cell Transplantation4
STAT3 Promotes Cell Proliferation by Potentiating the CCL4 Transcriptional Activity in Diffuse Large B-Cell Lymphoma3
Association between Platelet-Associated Immunoglobulin G Levels and Response to Corticosteroid Therapy in Patients with Newly Diagnosed Immune Thrombocytopenia3
MiR-199a-3p Overexpression Suppressed Cell Proliferation and Sensitized Chronic Myeloid Leukaemia Cells to Imatinib by Inhibiting mTOR Signalling3
Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer3
Patient Involvement in the Transfusion Decision-Making Can Change Patient Blood Management Practice for Better or Worse3
Prognostic Markers in the Era of Targeted Therapies3
Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study3
Significance of the p.Phe218Ser and p.Gly304Glu F5 Variants in Hereditary Factor V Deficiency3
Safety and Feasibility Analysis of a Prospective Trial on Stereotactic Body Radiotherapy for Solitary Bone Plasmacytoma3
PNH Clones for Aplastic Anemia with Immunosuppressive Therapy: A Systematic Review and Meta-Analysis3
Resolution of Melanoma to Programmed Death-1 Blockade but Simultaneous Rapid Progression of Concomitant Chronic Lymphocytic Leukemia3
Survival Disparities in Multiple Myeloma by Health Insurance Status among US Non-Elderly Adults: A SEER-Based Comparative Analysis3
Effects of Glycosaminoglycan from <b><i>Urechis unicinctus</i></b> on ADP-Induced Platelet Calcium and Membrane Glycoprotein Expressions in Rats3
Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes3
Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma3
Gilteritinib in Isolated Breast Relapse of <b><i>FLT3</i></b> Positive Acute Myeloid Leukemia: A Case Report and Review of Literature3
Efficacy and Incidence of Treatment-Related Adverse Events of Thrombopoietin Receptor Agonists in Adults with Immune Thrombocytopenia: A Systematic Review and Network Meta-Analysis of Randomized Contr3
Use of Core-Needle Biopsy for the Diagnosis of Malignant Lymphomas in Clinical Practice3
Phase II, Multicenter, Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of Panobinostat in Combination with Bortezomib and Dexamethasone in Japanese Patients with Relapsed or Relapsed-3
Chronic Eosinophilic Leukaemia Associated with <b><i>JAK2</i></b> Exon 13 Insertion/Deletion Mutations3
Acute Myeloid Leukemia with NPM1 Mutation and Disseminated Leukemia Cutis: Achievement of Molecular Complete Remission by Venetoclax/Azacitidine Combination in a Very Old Patient3
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa3
Splenectomy Outcomes in Relapsed or Refractory Immune Thrombocytopenia according to First-Line Intravenous Immunoglobulin Response3
0.046630144119263